This document contains an agenda and details for multiple presentations. It discusses appropriate labeling and timing of specimen collection, and outlines the primary goals, areas of growth, and timeline for annual revenue growth. It also introduces the presenting team and extended team members, and details plans for product launch including timelines for planning, marketing, design, strategy, and launch. Areas of focus are discussed on B2B market scenarios and cloud-based opportunities. The summary emphasizes Contoso's next-generation data architecture and great team behind their product.

1. Presentation title
Mirjam Nilsson​

2. Agenda
Introduction
Primary goals
Areas of growth
Timeline
Summary
Presentation title 2

3. Introduction
1. Labeling. Appropriate information is critical to proper processing of test requests. Although pertinent clinical information is highly desirable, if it is not available, please provide at least the following information.
a. Patient's name
b. Source of specimen or collection site
c. Date
d. Specimen and lesion status
e. Test desired
2. Obtain specimen correctly.
a. Explain completely to the patient.
b. Use a sterile container.
c. Label correctly and send the specimen to the laboratory promptly.
d. Avoid contamination of the container.
Note: Please examine specimen collection and transportation supplies to be sure they do not include expired containers.
3. Timing of collection.
a. Sputum, urine, stool, etc. are best collected in early morning and sent to the laboratory the same day.
b. Blood
• A blood culture requires two bottles of blood—one for aerobic and one for anaerobic culture. Each blood culture should be collected from a separate venipuncture.
• Collect blood specimens before antimicrobial treatment is initiated, if possible.
• Collect two or three sets early in the illness; repeat if they are negative after 48 hours of growth.
• Organisms are continuously shed during intravascular infections, such as endocarditis, but they are intermittently shed during occult infections. In some instances of occult infection, there is a predictable fever pattern. If this is the case, the blood for culture is
best collected 30 minutes prior to the fever spike.
• The yield beyond three or four cultures is minimal in most circumstances, and collection of more than this is discouraged.
• Virtually any organism, including normal flora, can cause bacteremia. A negative culture result does not necessarily rule out bacteremia; false-negative results occur when pathogens fail to grow. A positive culture result does not necessarily indicate
bacteremia; false-positive results occur when contaminants grow. Gram-negative bacilli, anaerobes, and fungi should be considered pathogens until proven otherwise. The most difficult interpretation problem is to determine whether an organism that is usually considered normal skin flora is a
true pathogen.
Presentation title 3

4. Primary goals
Annual revenue growth

5. Quarterly performance
4.5
3.5
2.5
4.3
2.8
1.8
4.4
2.4
5.0
3.0
2.0 2.0
-
1.0
2.0
3.0
4.0
5.0
6.0
Q4 Q3 Q2 Q1
Series 3 Series 2 Series 1
Presentation title 5

6. Areas of growth
B2B Supply chain ROI E-commerce
Q1 4.5 2.3 1.7 5.0
Q2 3.2 5.1 4.4 3.0
Q3 2.1 1.7 2.5 2.8
Q4 4.5 2.2 1.7 7.0
Presentation title 6

7. Business opportunities are like
buses. There's always another
one coming.
“ Richard Branson
”

8. Meet our team
Takuma Hayashi​
President
Mirjam Nilsson​
Chief Executive Officer
Flora Berggren​
Chief Operations Officer
Rajesh Santoshi​
VP Marketing
Presentation title 8

9. Meet our extended team
Takuma Hayashi​
President
Graham Barnes
VP Product
Mirjam Nilsson​
Chief Executive Officer
Rowan Murphy
SEO Strategist
Flora Berggren​
Chief Operations Officer
Elizabeth Moore
Product Designer
Rajesh Santoshi​
VP Marketing
Robin Kline
Content Developer
Presentation title 9

10. Plan for product launch
Presentation title 10
Planning
Synergize scalable
e-commerce
Marketing
Disseminate
standardized
metrics
Design
Coordinate e-
business
applications
Strategy
Foster holistically
superior
methodologies
Launch
Deploy strategic
networks with
compelling e-
business needs

11. Timeline
Presentation title 11
Synergize scalable e-
commerce
Sep 20XX
Disseminate standardized
metrics
Nov 20XX
Coordinate e-business
applications
Jan 20XX
Foster holistically superior
methodologies
Mar 20XX
Deploy strategic networks with
compelling e-business needs
May 20XX

12. Areas of focus
B2B market scenarios
• Develop winning strategies to keep ahead of the
competition
• Capitalize on low-hanging fruit to identify a ballpark
value
• Visualize customer directed convergence
Cloud-based opportunities
• Iterative approaches to corporate strategy
• Establish a management framework from the inside
Presentation title 12

13. How we get there
ROI
• Envision multimedia-based
expertise and cross-media
growth strategies
• Visualize quality intellectual
capital
• Engage worldwide
methodologies with web-
enabled technologies
Niche markets
• Pursue scalable customer
service through sustainable
strategies
• Engage top-line web services
with cutting-edge deliverables
Supply chains
• Cultivate one-to-one customer
service with robust ideas
• Maximize timely deliverables
for real-time schemas
Presentation title 13

14. Summary
At Contoso, we believe in giving 110%. By using our next-generation
data architecture, we help organizations virtually manage agile
workflows. We thrive because of our market knowledge and great
team behind our product. As our CEO says, "Efficiencies will come
from proactively transforming how we do business."
Presentation title 14

15. Thank you
Mirjam Nilsson​
mirjam@contoso.co
m
www.contoso.com